STONEPINE CAPITAL, L.P. 4
4 · NOVELION THERAPEUTICS INC. · Filed Dec 12, 2019
Insider Transaction Report
Form 4
STONEPINE CAPITAL, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-12-10$0.69/sh+5,202$3,598→ 3,908,167 total - Purchase
Common Stock
2019-12-12$0.70/sh+1,000$700→ 3,909,207 total - Purchase
Common Stock
2019-12-11$0.69/sh+40$28→ 3,908,207 total